Latest

Politics Rachel Cohrs Zhang

STAT Plus: What do Biden’s drug price comparisons reveal? Not much

Biotech Meghana Keshavan

STAT Plus: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy

The Readout LOUD Allison DeAngelis, Elaine Chen, and Adam Feuerstein

Listen: Drug pricing drops & psychedelics under fire

Health Jason Mast

STAT Plus: Antiviral used for mpox no better than placebo, NIH says

Morning Rounds Theresa Gaffney

New Medicare drug prices, antimicrobial-resistant meningitis, unlucky American women

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: Boston’s lab market is in rough shape

Biotech Adam Feuerstein

STAT Plus: The business of CRISPR’d medicine: Not great

The Readout Elaine Chen

STAT Plus: We have mpox vaccines now. But how will they be distributed?

Politics John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Medicare drug price negotiation didn’t benefit Biden — but it may help Harris

Pharma Rachel Cohrs Zhang

STAT Plus: Medicare announces drug prices for historic first round of negotiations

Pharma Joseph Howlett and Andrea Tamayo

STAT Plus: Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs

First Opinion Evan Selinger and Thomas Carroll

Can AI help ease medicine’s empathy problem?

First Opinion David Introcaso

HHS says it is working to stop the climate crisis. But it’s really just climate washing

Health tech Timmy Broderick

STAT Plus: ALS patient lived with a brain-computer interface for 7 years. Here’s what researchers learned

Biotech Adam Feuerstein

STAT Plus: Gilead wins U.S. approval for drug to treat autoimmune liver disease

Health Helen Branswell

WHO declares mpox outbreak a global health emergency

Biotech Matthew Herper

STAT Plus: Eli Lilly’s billions: Can the world’s most valuable pharma company keep inventing drugs at this pace?

Morning Rounds Theresa Gaffney

Abortion, shingles, extreme heat, and sudden cardiac arrest

The Readout Elaine Chen

STAT Plus: Syros shares battered after it stops leukemia trial

First Opinion Nicholas DeVito

Ultra-processed foods: the tobacco of the 21st century?

Health Elizabeth Cooney

Sudden cardiac arrest requires luck to survive. Scientists hope to turn those odds around

First Opinion Gregory A. Poland

Better safety studies could restore America’s confidence in vaccines

Biotech Jonathan Wosen

STAT Plus: Grail announces layoffs as it looks to push forward blood-based cancer detection test

Biotech Jonathan Wosen

STAT Plus: Illumina lays out plan to boost growth by helping scientists interpret sequencing data

Biotech Jonathan Wosen

STAT Plus: Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug

D.C. Diagnosis Sarah Owermohle

The politics of mifepristone in the 2024 election

Morning Rounds Theresa Gaffney

Morning Rounds: The billionaire who wants you angry about the food supply

Health tech Mario Aguilar

STAT Plus: Otsuka prices depression digital therapeutic to make it widely accessible, says it’ll lose money

The Readout Elaine Chen

STAT Plus: Atai advances oral psychedelic in depression